Septerna is poised for a pivotal catalyst with upcoming Phase 1 data for SEP-631, targeting mast cell-driven diseases via ...
Venice’s ancient walls are unaccustomed to the scent of fresh paint, let alone street art. Taron Manukyan stood before that historical silence, a spray can in hand. In a city where every stone is a ...